Becton, Dickinson and Company (BDX)

業務介紹

貝克頓·迪金森公司（Becton, Dickinson and Company）在全球範圍內研發、製造和銷售醫療用品、設備、實驗室設備和診斷產品，面向醫療機構、醫生、生命科學研究人員、臨床實驗室、製藥行業和普通大眾。該公司的BD醫療部門提供周邊靜脈（IV）和先進周邊導管、中心導管、急性透析導管、血管護理和預備產品、無針IV連接器和延長套件、封閉系統藥物轉移裝置、危險藥物檢測、皮下注射器和針頭、麻醉針和托盤、腸道注射器和銳器處理系統；IV藥物和輸液治療系統、藥物混合工作流程系統、自動藥物分發和供應管理系統、藥物庫存優化和追踪系統；針筒、筆型針頭和其他糖尿病產品；以及可預先填充的藥物傳遞系統。其BD生命科學部門提供標本和血液收集產品；自動化血液和結核菌培養、分子檢測、微生物鑒定和藥物敏感性測試、液基細胞學系統，以及快速診斷試劑盒、微生物學實驗室自動化產品和平板培養基產品；以及螢光活化細胞分選和分析儀、抗體和試劑盒、試劑系統，以及用於單細胞基因表達分析的解決方案，以及臨床腫瘤學、免疫學和移植診斷/監測試劑和分析儀。該公司的BD介入部門提供疝氣和軟組織修復、生物和可吸收移植物、生物手術和其他外科產品；外科感染預防、外科和腹腔鏡手術儀器產品；周邊介入產品；以及泌尿學和重症護理產品。該公司成立於1897年，總部位於新澤西州富蘭克林湖。

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

公司網址

https://www.bd.com